Prenatal dexamethasone use for the prevention of virilization in pregnancies at risk for classical congenital adrenal hyperplasia because of 21-hydroxylase (CYP21A2) deficiency: a systematic review and meta-analyses. (Q34120892)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prenatal dexamethasone use for the prevention of virilization in pregnancies at risk for classical congenital adrenal hyperplasia because of 21-hydroxylase (CYP21A2) deficiency: a systematic review and meta-analyses. |
scientific article |
Statements
Prenatal dexamethasone use for the prevention of virilization in pregnancies at risk for classical congenital adrenal hyperplasia because of 21-hydroxylase (CYP21A2) deficiency: a systematic review and meta-analyses (English)
Patricia J Erwin
Julianna F Lampropulos
Khalid B Elamin
Kalpana Muthusamy
Neera Agrwal
M Mercè Fernández-Balsells
Galina Smushkin
Mohamed B Elamin
Juan F Gallegos-Orozco
Melanie A Lane
1 October 2010